Results for “”

Entry Author Date Location
Vesigen Nabs $28M to Wrap “ARMMS” Around Large Molecule Drug Delivery 07/22/20 Boston
Seer Raises $55M to Commercialize Tools to Analyze the Proteome 07/22/20 San Francisco
Olema Adds $54M to Start Human Tests of Breast Cancer Drug Candidate 07/22/20 San Francisco
Freeline Therapeutics and Checkmate Pharma Make Opening IPO Moves 07/21/20 Europe
Elevation Oncology Debuts With $32.5M to Develop Targeted Cancer Drugs 07/21/20 New York
Roche, Jnana Enter Drug R&D Alliance Targeting Metabolism’s Gatekeepers 07/21/20 Boston
Gilead Sciences Splashes Out $300M for Tizona Stake & Option to Acquire 07/21/20 San Francisco
Acadia Halts Work on Depression Drug After Late-Stage Trial Failure 07/21/20 San Diego
Forge Bio’s Combo Model for Gene Therapies Attracts $40M in Funding 07/21/20 National
GSK Pays CureVac $328M in mRNA Vaccines Pact—Excluding COVID-19 07/20/20 Europe
Exalys Launches With $15M to Treat Postoperative Delirium & More 07/17/20 San Diego
MeiraGTx, J&J See Phase 3 Test Ahead for Vision Loss Gene Therapy 07/17/20 New York
Two Days, Six IPOs, and $1B Raised for Biotech Research & More 07/17/20 National
Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More 07/17/20 National
Adimab Spinout Adagio Raises $50M for Coronavirus Antibody R&D 07/16/20 Boston
Mallinckrodt’s Kidney Failure Drug Narrowly Wins Backing of FDA Panel 07/16/20 Europe
Moderna Publishes Early COVID-19 Vaccine Data, Preps for Phase 3 Test 07/15/20 Boston
Last Chance for Xconomy Awards Nominations – Deadline is Friday, July 17 07/15/20 Boston
Dewpoint, Merck Team Up to Tackle HIV Using Condensate Know-How 07/15/20 Boston
After Biologic COVID-19 Drug OK’d in India, Equillium Plans a US Test 07/14/20 San Diego
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact 07/14/20 Boston
New Xconomy Podcast & Special Report Feature Boston Biophama Leaders on Digital Health 07/14/20 Boston
Amgen Doubles Down on BeiGene Collaboration, Investing $421M More 07/13/20 San Francisco
3 Biotech IPOs Together Rake In Over a Half Billion to Advance Treatments 07/13/20 National
Ovid Licenses European Rights to Lead Rare Disease Drug to Angelini Pharma 07/13/20 Boston
Bio Roundup: Blackstone’s Billions, Biogen Finishes Filing, Novavax at “Warp Speed” & More 07/10/20 National
Sanofi Pays Kymera $150M to Kick Off Protein Degrader Partnership 07/09/20 Boston
NFlection Looks to Erase NF1 Tumors With Drug That Only Goes Skin Deep 07/09/20 Philadelphia
VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs 07/09/20 San Diego
Biogen Alzheimer’s Drug in FDA’s Court Following Completion of Filing 07/08/20 Boston
Page 2 of 1971 « previous page · next page »